- Abu Dhabi Investment Authority (ADIA) joins a $200 million Seed funding round for Lila Sciences.
- The AI-driven biotech company specializes in life sciences, chemistry, and material sciences.
- Other investors include Blue Horizon Advisors, Modi Ventures, March Capital, ARK Venture Fund, and General Catalyst.
ADIA Strengthens Its AI Investment Portfolio
The Abu Dhabi Investment Authority (ADIA) has announced its participation in a $200 million Seed funding round for Lila Sciences, a U.S.-based company focused on developing AI-powered platforms for scientific research in life sciences, chemistry, and material sciences.
This investment aligns with ADIA’s long-term strategy of focusing on cutting-edge technologies, particularly artificial intelligence.
Lila Sciences: Advancing AI-Powered Research
Founded in 2023, Lila Sciences is at the forefront of developing AI-driven research platforms and autonomous laboratories. The company leverages robotics and automation to streamline experiment design and hypothesis testing, accelerating breakthroughs in scientific research.
A High-Profile Investor Consortium
Alongside ADIA, the funding round attracted leading investment firms, including:
- Blue Horizon Advisors
- Modi Ventures
- March Capital
- ARK Venture Fund
- General Catalyst
ADIA’s Expanding AI Investments
This investment further reflects ADIA’s growing focus on AI technologies. The sovereign wealth fund recently invested $1 billion in Qlik, a U.S.-based data analytics firm, and $500 million in AlphaGen, a company specializing in energy sector AI solutions.
ADIA’s Global Investment Leadership
Established in 1976, the Abu Dhabi Investment Authority is one of the largest sovereign wealth funds globally, managing approximately $1.1 trillion in assets. The fund focuses on long-term investments that deliver sustainable value and technological innovation across diverse sectors.
